Scynexis (SCYX) Current Assets (2013 - 2026)
Scynexis' (SCYX) quarterly Current Assets came in at $62.7 million in Q1 2026, up 20.05% YoY from $52.2 million in Q1 2025, and up 55.28% on a QoQ basis from $40.4 million in Q4 2025.
Scynexis (SCYX) Current Assets (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Current Assets data on file, last reported at $62.7 million in Q1 2026.
- Quarterly Current Assets rose 20.05% year-over-year to $62.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.7 million (up 20.05% YoY) and the FY2025 annual result came in at $40.4 million, down 44.07% from the prior year.
- Current Assets rose to $62.7 million in Q1 2026, from $40.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $145.5 million in Q2 2023 to a low of $40.4 million in Q4 2025.
- A 5-year average of $85.6 million and a median of $80.5 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets jumped 70.12% — and 2025, when it sank 48.64%.
- Tracing SCYX's Current Assets over 5 years: stood at $79.1 million in 2022, then increased by 29.16% to $102.1 million in 2023, then retreated by 29.31% to $72.2 million in 2024, then slumped by 44.07% to $40.4 million in 2025, then surged by 55.28% to $62.7 million in 2026.
- The last three Current Assets figures came in at $62.7 million (Q1 2026), $40.4 million (Q4 2025), and $48.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | 56.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.24 Mn |
| Mar 31, 2026 | 62.69 Mn |
| Dec 31, 2025 | 40.37 Mn |
| Sep 30, 2025 | 48.69 Mn |
| Jun 30, 2025 | 56.50 Mn |
| Mar 31, 2025 | 52.22 Mn |
| Dec 31, 2024 | 72.18 Mn |
| Sep 30, 2024 | 80.46 Mn |
| Jun 30, 2024 | 94.58 Mn |
| Mar 31, 2024 | 101.67 Mn |
| Dec 31, 2023 | 102.12 Mn |
| Sep 30, 2023 | 128.64 Mn |
| Jun 30, 2023 | 145.53 Mn |
| Mar 31, 2023 | 59.77 Mn |
| Dec 31, 2022 | 79.06 Mn |
| Sep 30, 2022 | 103.57 Mn |
| Jun 30, 2022 | 125.68 Mn |
| Mar 31, 2022 | 101.91 Mn |
| Dec 31, 2021 | 109.38 Mn |
| Sep 30, 2021 | 103.93 Mn |